OZEMPIC (SEMAGLUTIDE)

0.25 mg or 0.5 mg (2 mg/1.5 mL) subcutaneous pen injector

• Inject 0.25 mg by subcutaneous route once weekly for 4 weeks then inject 0.5 mg subcutaneously once weekly using rotating injection sites

1 mg/dose (2 mg/1.5 mL) subcutaneous pen injector

• Inject 1 mg by subcutaneous route once weekly on the same day of eachweek, in the abdomen, thighs, or upper arm rotating injection sites

Type 2 diabetes mellitus

• Inject 0.2 milliliter (0.25 mg) by subcutaneous route once weekly on the same day of each week, in the abdomen, thighs, or upper arm rotating injection sites

• Inject 0.4 milliliter (0.5 mg) by subcutaneous route once weekly on the same day of each week, in the abdomen, thighs, or upper arm rotating injection sites

• Inject 0.5 mg by subcutaneous route once weekly on the same day of each week, in the abdomen, thighs, or upper arm rotating injection sites

• Inject 0.25 mg by subcutaneous route once weekly on the same day of each week, in the abdomen, thighs, or upper arm rotating injection sites

• Inject 1 mg by subcutaneous route once weekly on the same day of eachweek, in the abdomen, thighs, or upper arm rotating injection sites

• Inject 0.25 mg by subcutaneous route once weekly for 4 weeks then inject 0.5 mg subcutaneously once weekly using rotating injection sites

• Inject 0.75 milliliter (1 mg) by subcutaneous route once weekly on the same day of each week, in the abdomen, thighs, or upper arm rotatinginjection sites